2017 ASX Announcements

Due to legal restrictions, only residents of Australia and New Zealand may access ASX announcements that contain information or materials relating to any capital raising.



Keyword Search
 
2018 | 2017
DateTitle 
22 December 2017Change of Director's Interest Notice
... 
Download PDF
21 December 2017Mesoblast Receives RMAT For LVAD Heart Failure Patients
... 
Download PDF
20 December 2017Release of shares from voluntary escrow
... 
Download PDF
20 December 2017Mesoblast's P3 GVHD Trial Completes Enrollment
... 
Download PDF
15 December 2017Mesoblast Grants TiGenix License For Treatment of Fistulae
... 
Download PDF
08 December 2017MSB Named Global Technology Leader In Cell Therapy Industry
... 
Download PDF
07 December 2017Change in substantial holding
... 
Download PDF
05 December 2017Change in substantial holding
... 
Download PDF
17 November 2017Response to ASX Aware Letter Query
... 
Download PDF
16 November 2017Results of Meeting
... 
Download PDF
16 November 2017CEO Presentation to 2017 Annual General Meeting
... 
Download PDF
16 November 2017Chairman's Address to Shareholders
... 
Download PDF
15 November 2017Ceasing to be a substantial holder
... 
Download PDF
15 November 2017Mesoblast Provides Corporate Update and Q1 Financial Results
... 
Download PDF
15 November 2017First Quarter Results Presentation
... 
Download PDF
15 November 2017First Quarter Results On Form 6K
... 
Download PDF
13 November 2017Becoming a substantial holder
... 
Download PDF
13 November 2017RA Phase 2 Trial Results Presented At ACR Annual Meeting
... 
Download PDF
09 November 2017Mesoblast Presents At Credit Suisse Healthcare Conference
... 
Download PDF
31 October 2017Appendix 4C - quarterly
... 
Download PDF
30 October 2017Ceasing to be a substantial holder
... 
Download PDF
27 October 2017Ceasing to be a substantial holder
... 
Download PDF
27 October 2017Becoming a substantial holder
... 
Download PDF
16 October 2017Annual Report to shareholders
... 
Download PDF
16 October 2017Notice of Annual General Meeting/Proxy Form
... 
Download PDF
16 October 2017Appendix 4G and Corporate Governance Statement
... 
Download PDF
06 October 2017Appendix 3B
... 
Download PDF
28 September 2017End-Stage Heart Failure Trial Completes Enrollment
... 
Download PDF
25 September 2017Mesoblast Corporate Updates at Healthcare Conferences
... 
Download PDF
25 September 2017Change of Director's Interest Notices
... 
Download PDF
18 September 2017Appendix 3B
... 
Download PDF
15 September 2017Mesoblast Completes A$50.7 Million Raise
... 
Download PDF
06 September 2017Change of Director Interest and Substantial Holding Notices
... 
Download PDF
06 September 2017Change in substantial holding
... 
Download PDF
01 September 2017Retail Entitlement Offer
... 
Download PDF
30 August 2017Mesoblast Reports on Annual and Fourth Quarter Results
... 
Download PDF
30 August 2017Preliminary Final Report including Appendix 4E
... 
Download PDF
30 August 2017Annual Financial Results Presentation
... 
Download PDF
29 August 2017Underwritten A$50.7M Raise Closes Institutional Allocation
... 
Download PDF
25 August 2017Cleansing notice
... 
Download PDF
25 August 2017Appendix 3B
... 
Download PDF
25 August 2017Fully Underwritten Entitlement Offer Presentation
... 
Download PDF
25 August 2017Fully Underwritten A$50.7 Million Entitlement Offer
... 
Download PDF
25 August 2017Trading Halt
... 
Download PDF
23 August 2017Potential For Accelerated Market Entry In Advanced CHF
... 
Download PDF
16 August 2017Positive Results of MSB Therapy in Osteoarthritis Published
... 
Download PDF
08 August 2017Release of shares from voluntary escrow
... 
Download PDF
31 July 2017Appendix 4C - quarterly
... 
Download PDF
13 July 2017Change in substantial holding
... 
Download PDF
10 July 2017Cleansing notice and Appendix 3B
... 
Download PDF
22 June 2017Mesoblast RA Results Presented At EULAR Congress
... 
Download PDF
25 May 2017MSB Provides Q3 Operational Highlights and Financial Results
... 
Download PDF
25 May 2017Third Quarter Results Presentation
... 
Download PDF
25 May 2017Third Quarter Financial Results On Form 6-K
... 
Download PDF
02 May 2017Change of Director's Interest Notice
... 
Download PDF
28 April 2017Appendix 4C - quarterly
... 
Download PDF
24 April 2017Change in substantial holding
... 
Download PDF
10 April 2017Successful Interim Analysis in Phase 3 Heart Failure Trial
... 
Download PDF
06 April 2017Mesoblast Receives A$3.7m From Aus Govt For R&D
... 
Download PDF
04 April 2017FDA Clears Heart Disease Trial At Boston Childrens Hospital
... 
Download PDF
03 April 2017Change in substantial holding
... 
Download PDF
31 March 2017Becoming a substantial holder from TEK
... 
Download PDF
31 March 2017Cleansing notice and Appendix 3B
... 
Download PDF
31 March 2017Process Initiated For CHF P3 Interim Analysis
... 
Download PDF
27 March 2017Mesoblast Raises US$40 Million
... 
Download PDF
15 March 2017Durable Three Year Outcomes in Disc Disease
... 
Download PDF
07 March 2017FDA Grants Mesoblast Fast Track Designation For GVHD
... 
Download PDF
27 February 2017Mesoblast Provides Half Year Results And Corporate Update
... 
Download PDF
27 February 2017Half Year Results Presentation
... 
Download PDF
27 February 2017Half Year Report and Accounts (including Appendix 4D)
... 
Download PDF
16 February 2017Presentation On Mesoblast RA P2 9 Month Trial Results
... 
Download PDF
16 February 2017Positive Nine Month RA Results For Mesoblast Cell Therapy
... 
Download PDF
13 February 2017Published Results Show MSB Cells Effective In RA Model
... 
Download PDF
10 February 2017Release of shares from voluntary escrow
... 
Download PDF
31 January 2017Appendix 4C - quarterly
... 
Download PDF
31 January 2017Mesoblast Director Recognized For Cardiovascular Leadership
... 
Download PDF
13 January 2017MSB Presentation To Annual J.P.Morgan Healthcare Conference
... 
Download PDF
11 January 2017Presentation at JP Morgan Healthcare Conference
... 
Download PDF
09 January 2017MSB Receives A$29.6Million, Appendix 3B Share Issue
... 
Download PDF

Share Price ASX: MSB  AUD 1.55 as of Aug 17, 2018